Skip to main content
. 2014 Oct 1;178(2):229–235. doi: 10.1111/cei.12410

Fig. 2.

Fig. 2

Peripheral blood mononuclear cell (PBMCs) microRNA (miR)-125a expression in study groups. The PBMC miR-125a expression level in patients with autoimmune thyroid diseases (AITDs) and control subjects (a), with different prognoses of Graves' disease (GD) (b) and Hashimoto's disease (HD) (c). A Student's t-test was used to compare the expression level of miR-125a between two groups and Dunnett's test was used between three groups.